Director's Purchase Activity at Atea Pharmaceuticals Signals Internal Confidence
A director at Atea Pharmaceuticals, Inc. (NASDAQ:AVIR), recently acquired a block of company common stock. The purchase was recorded via an amended Form 4 filing. This activity occurs against the backdrop of recent financial disclosures, where the company reported its Q1 2026 earnings and emphasized its strong cash position and strategic focus on H…